Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LeafyQuick is a Chicago-based private company that operates an e-commerce and delivery platform focused on legal CBD and related endocannabinoid products, and has also expanded into telehealth-enabled medical cannabis card services through LeafyQuick Wellness/LeafyQuickMD. The business curates products from third-party brands and local retailers, offering online discovery, ordering, recurring delivery, and last-mile logistics rather than developing proprietary therapeutics. Public sources describe the company as one of the first same-day CBD delivery platforms in Chicago, with additional services for patients seeking access to licensed physicians for medical cannabis certification in multiple U.S. states. For a biotech analyst, LeafyQuick is better characterized as a commercial cannabis-health access and wellness platform than as a drug developer, biotech, or pharmaceutical company. There is no evidence from available public sources of an internal therapeutic pipeline, proprietary drug candidates, or clinical-stage R&D programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LeafyQuick.